Yuho Najima

5.2k total citations
98 papers, 2.7k citations indexed

About

Yuho Najima is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Yuho Najima has authored 98 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Hematology, 21 papers in Genetics and 21 papers in Oncology. Recurrent topics in Yuho Najima's work include Hematopoietic Stem Cell Transplantation (41 papers), Acute Myeloid Leukemia Research (31 papers) and Acute Lymphoblastic Leukemia research (20 papers). Yuho Najima is often cited by papers focused on Hematopoietic Stem Cell Transplantation (41 papers), Acute Myeloid Leukemia Research (31 papers) and Acute Lymphoblastic Leukemia research (20 papers). Yuho Najima collaborates with scholars based in Japan and United States. Yuho Najima's co-authors include Yoriko Saito, Fumihiko Ishikawa, Leonard D. Shultz, Nahoko Suzuki, Satoshi Tanaka, Ryozo Nagai, Hitoshi Shimano, Naoya Yahagi, Jun-ichi Osuga and Nobuhiro Yamada and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Yuho Najima

83 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuho Najima Japan 18 1.0k 834 693 578 481 98 2.7k
Serhan Alkan United States 30 1.3k 1.3× 526 0.6× 1.2k 1.7× 478 0.8× 615 1.3× 104 3.3k
Adalberto Benito Spain 19 1.3k 1.3× 738 0.9× 553 0.8× 1.2k 2.0× 343 0.7× 37 3.3k
Yasunobu Abe Japan 30 738 0.7× 421 0.5× 922 1.3× 608 1.1× 724 1.5× 163 3.5k
Tadakazu Kondo Japan 31 1.0k 1.0× 1.1k 1.3× 1.1k 1.5× 734 1.3× 433 0.9× 196 3.3k
Wenbin Qian China 30 1.4k 1.4× 616 0.7× 997 1.4× 585 1.0× 374 0.8× 170 2.8k
Rosana Pelayo Mexico 25 851 0.8× 606 0.7× 343 0.5× 1.7k 2.9× 346 0.7× 80 3.0k
Daniel M. Jones United States 25 1.4k 1.4× 624 0.7× 370 0.5× 250 0.4× 569 1.2× 71 3.3k
Ildiko Konrad Germany 18 750 0.7× 1.4k 1.7× 263 0.4× 1.1k 1.9× 335 0.7× 20 3.3k
Astrid Gruber Sweden 34 1.8k 1.8× 643 0.8× 927 1.3× 343 0.6× 445 0.9× 99 3.5k
Sumio Sakamaki Japan 28 1.0k 1.0× 819 1.0× 924 1.3× 499 0.9× 305 0.6× 88 3.3k

Countries citing papers authored by Yuho Najima

Since Specialization
Citations

This map shows the geographic impact of Yuho Najima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuho Najima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuho Najima more than expected).

Fields of papers citing papers by Yuho Najima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuho Najima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuho Najima. The network helps show where Yuho Najima may publish in the future.

Co-authorship network of co-authors of Yuho Najima

This figure shows the co-authorship network connecting the top 25 collaborators of Yuho Najima. A scholar is included among the top collaborators of Yuho Najima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuho Najima. Yuho Najima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toya, Takashi, et al.. (2025). Real‐World Efficacy of Extending Duration of Letermovir Prophylaxis for Allogeneic Stem Cell Recipients. Transplant Infectious Disease. 27(6). e70116–e70116.
2.
Toya, Takashi, et al.. (2025). Recent Advances in the Prognosis of HHV-6 Encephalitis Following Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 31(7). 463.e1–463.e12.
5.
Kurosawa, Shuhei, Yuho Najima, Satoshi Wakita, et al.. (2024). Overcoming post‐transplant graft failure and adenovirus infection in a patient with FLT3‐TKD‐mutated mixed‐phenotype acute leukemia: A case report. SHILAP Revista de lepidopterología. 5(4). 802–809. 1 indexed citations
6.
Onozawa, Masahiro, Shigeru Kusumoto, Yuho Najima, et al.. (2024). Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study. Transplantation and Cellular Therapy. 30(3). 330.e1–330.e8.
7.
Fuji, Shigeo, Junichi Sugita, Yuho Najima, et al.. (2023). Low‐ versus standard‐dose post‐transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation. British Journal of Haematology. 204(3). 959–966. 6 indexed citations
9.
Toya, Takashi, Takahiro Sanada, Tomoko Honda, et al.. (2022). Attenuated humoral response against SARS‐CoV‐2 mRNA vaccination in allogeneic stem cell transplantation recipients. Cancer Science. 114(2). 586–595. 6 indexed citations
10.
Toya, Takashi, Takahiro Sanada, Tomoko Honda, et al.. (2022). A third dose of COVID‐19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant. SHILAP Revista de lepidopterología. 4(1). 309–311. 1 indexed citations
11.
Kurosawa, Shuhei, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.. (2021). Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis. Bone Marrow Transplantation. 56(12). 3008–3015. 5 indexed citations
12.
Kurosawa, Shuhei, Takashi Toya, Tsunekazu Hishima, et al.. (2021). Mutation profiles of diffuse large B‐cell lymphoma transformation of splenic B‐cell lymphoma/leukemia, unclassifiable on whole‐exome sequencing. SHILAP Revista de lepidopterología. 2(4). 854–860. 2 indexed citations
13.
Najima, Yuho, Yuka Harada, Keisuke Oboki, et al.. (2020). Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT. Bone Marrow Transplantation. 56(2). 334–346. 12 indexed citations
14.
Sekiya, Noritaka, Yuho Najima, Kazuaki Fukushima, et al.. (2020). Nontuberculous mycobacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation. International Journal of Infectious Diseases. 97. 131–134. 9 indexed citations
15.
Kaito, Satoshi, Yuho Najima, Kaito Harada, et al.. (2020). Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype. Bone Marrow Transplantation. 55(7). 1337–1346. 5 indexed citations
16.
Doki, Noriko, Yutaro Hino, Shuntaro Ikegawa, et al.. (2019). [Transfusion-associated circulatory overload with pulmonary alveolar hemorrhage following allogeneic bone marrow transplantation].. PubMed. 60(4). 296–301.
17.
Najima, Yuho, Chikashi Yoshida, Noriyoshi Iriyama, et al.. (2018). Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study. Leukemia Research. 66. 66–72. 29 indexed citations
19.
Terakura, Seitaro, Yoshiko Atsuta, Nobuhiro Tsukada, et al.. (2015). Comparison of Outcomes of 8/8 and 7/8 Allele–Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia. Biology of Blood and Marrow Transplantation. 22(2). 330–338. 79 indexed citations
20.
Yahagi, Naoya, Hitoshi Shimano, Kiyoshi Hasegawa, et al.. (2005). Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. European Journal of Cancer. 41(9). 1316–1322. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026